Creatio has joined the EIC Ecosystem Partnership Programme as an EIC Partner, an initiative driven by the European Innovation Council (EIC) and the European Innovation Council and SMEs Executive Agency (EISMEA) that promotes strategic collaborations across Europe between EIC beneficiaries and EIC Partners.
Read more
8 June, 2026
Creatio coordinates VISI-ON-BRAIN, a European doctoral program funded by Horizon Europe with 4.54 million euros to train researchers in advanced in vitro and in silico technologies applied to the study of cerebral diseases, promoting innovative alternatives to animal experimentation.
Read more
4 June, 2026
FIRST CENTER IN SPAIN TO PRODUCE LENTIVIRUSES FOR CAR-T (CHIMERIC ANTIGEN RECEPTOR-T) CELLS IN CLINICAL TRIALS
Read more
3 October, 2022
THE WORLD'S LARGEST FOUNDATION IN THE SEARCH FOR A CURE FOR NEURODEGENERATIVE HUNTINGTON'S DISEASE, CHDI, HAS SHOWN CONTINUED TRUST IN CREATIO FOR THE PAST FEW YEARS.
Read more
22 May, 2020
FIRST ACCREDITATION FROM THE AEMPS FOR THE VIRAL PRODUCTION OF MEDICINES
Read more
15 June, 2016